Wells Fargo & Company Actinium Pharmaceuticals, Inc. Put Options Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ATNM
# of Institutions
70Shares Held
7.94MCall Options Held
59.6KPut Options Held
4.8K-
Black Rock Inc. New York, NY1.88MShares$2.34 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$2.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$859,8160.0% of portfolio
-
State Street Corp Boston, MA621KShares$776,3430.0% of portfolio
-
Acadian Asset Management LLC Boston, MA499KShares$624,0750.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $31.5M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...